TuHURA Biosciences Completes Acquisition of Kineta
30 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences Begins Phase 3 Trial of IFx-2.0 with Keytruda®
24 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences, Kineta Stockholders Approve Merger
23 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences, Inc. Reports Q1 2025 Results and Update
15 May 2025 //
PR NEWSWIRE
TuHURA Biosciences & Kineta Present Updated Results at AACR Meeting
28 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Abstracts Accepted for 2025 AACR Meeting
08 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Names Dr. Bertrand Le Bourdonnec EVP, He
07 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Reports Fiscal Year 2024 Results
01 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D. to Board
11 Mar 2025 //
ACCESSWIRE
TuHURA Biosciences to Present at 37th Annual ROTH Conference
10 Mar 2025 //
ACCESSWIRE